Brigatinib, an anaplastic lymphoma kinase inhibitor, abrogates activity and growth in ALK-positive neuroblastoma cells, Drosophila and mice

Kathrin Pfeifer

Postdoctoral Researcher

Ruth Palmer

Professor at Department of Biochemistry and Cell Biology

I want to impart those around me with my enthusiasm for research and to train the next generation scientist.